Patient Monitoring Devices Market to Grow from USD 55.60 Billion in 2026 to USD 76.11 Billion by 2031, at a CAGR of 6.4%- MarketsandMarkets™

Delray Beach, FL, Aug. 05, 2026 (GLOBE NEWSWIRE) -- MarketsandMarkets™ projects the global patient monitoring devices market will grow from USD 55.60 billion in 2026 to USD 76.11 billion by 2031, at a CAGR of 6.4% during the forecast period. Market growth is fueled by the rising prevalence of chronic diseases, increasing aging population, growing demand for continuous patient monitoring, and expanding adoption of connected healthcare technologies. Continuous advancements in wearable monitoring devices, AI-enabled analytics, remote patient monitoring platforms, wireless connectivity, and digital health ecosystems are further accelerating the adoption of patient monitoring devices across hospitals, ambulatory care centers, and home healthcare settings worldwide.

Get PDF Brochure — Market Data & Segmentation: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=678

Key Market Highlights

Market size, 2026: USD 55.60 billion
Market forecast, 2031: USD 76.11 billion
Growth rate: CAGR of 6.4% (2026–2031)
Largest end-user segment: Hospitals & clinics
Largest product segment: Blood glucose monitoring devices
Key growth opportunity: Remote patient monitoring and home healthcare
Major growth drivers: Rising prevalence of chronic diseases, increasing adoption of connected healthcare, wearable monitoring technologies, and AI-enabled patient monitoring systems
Leading companies: Medtronic Plc. (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), Edwards Lifesciences Corporation (US), Getinge AB (Sweden), Baxter International Inc. (US), Masimo Corporation (US), and Boston Scientific Corporation (US).

Why This Market Matters

Patient monitoring devices have become an essential component of modern healthcare by enabling continuous assessment of vital physiological parameters across hospitals, intensive care units, ambulatory care centers, and home healthcare settings. The increasing burden of cardiovascular diseases, diabetes, respiratory disorders, and hypertension is driving demand for continuous monitoring solutions that support early diagnosis, timely intervention, and improved disease management. Simultaneously, healthcare providers are increasingly adopting connected healthcare platforms, wearable technologies, remote monitoring solutions, and AI-enabled analytics to improve patient outcomes while reducing hospital readmissions and healthcare costs.

Market Overview

The patient monitoring devices market is undergoing significant transformation as healthcare systems shift from traditional bedside monitoring toward intelligent, connected, and patient-centric monitoring platforms. Digital health ecosystems integrating wearable sensors, wireless connectivity, artificial intelligence, telehealth, and cloud-based analytics are improving real-time clinical decision-making across acute care, ambulatory care, and home healthcare environments. Although alternative diagnostic approaches and increasing adoption of refurbished monitoring devices present market challenges, ongoing investments in healthcare infrastructure and digital healthcare transformation continue to support long-term market expansion.

Analyst Perspective

The patient monitoring industry is evolving beyond conventional monitoring equipment into integrated digital healthcare ecosystems. Manufacturers are increasingly focusing on compact wearable devices, software-enabled monitoring platforms, AI-driven predictive analytics, remote patient monitoring, and seamless interoperability with electronic health records. As healthcare providers continue emphasizing preventive care, personalized medicine, and home-based healthcare, companies that successfully integrate connected technologies with intelligent clinical decision support systems will strengthen their competitive advantage over the coming years.

Speak to Our Analyst — Get Custom Insights: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=678

Segment Analysis

By product, blood glucose monitoring devices account for a significant share of the patient monitoring devices market, driven by the increasing prevalence of diabetes and growing demand for continuous glucose monitoring (CGM), wearable glucose monitoring devices, and connected disease management solutions. Other major product categories include ECG devices, pulse oximeters, blood pressure monitors, fetal & neonatal monitors, EEG systems, spirometers, and implantable loop recorders (ILRs).

By end user, hospitals and clinics accounted for the largest market share owing to increasing patient admissions, rising prevalence of chronic diseases, and growing demand for continuous monitoring in emergency, critical care, and intensive care settings. Increasing investments in connected monitoring platforms and integrated healthcare technologies are further supporting segment growth.

Regional Analysis

Rapid improvements in healthcare infrastructure across Asia Pacific, Latin America, and the Middle East & Africa are creating significant growth opportunities for patient monitoring device manufacturers. Increasing government investments in hospitals, specialty care centers, digital healthcare programs, and health insurance coverage are improving access to advanced monitoring technologies. The growing adoption of connected healthcare, wearable devices, and remote patient monitoring solutions across emerging markets is expected to support sustained market expansion over the forecast period.

Key Industry Trends

Increasing adoption of AI-enabled patient monitoring platforms
Growing demand for wearable and wireless monitoring devices
Expansion of remote patient monitoring and home healthcare
Integration of cloud-based analytics and telehealth platforms
Rising adoption of continuous glucose monitoring (CGM) technologies
Growing focus on connected healthcare ecosystems and personalized care
Increasing development of compact, software-driven monitoring solutions

Competitive Landscape

The patient monitoring devices market is highly competitive, with leading companies collectively accounting for approximately 70–72% of the global market in 2026. Major market participants include Medtronic Plc. (Ireland), Abbott Laboratories (US), Dexcom, Inc. (US), GE HealthCare (US), Philips Healthcare (Netherlands), Nihon Kohden Corporation (Japan), Mindray Medical International Ltd. (China), Edwards Lifesciences Corporation (US), Getinge AB (Sweden), Baxter International Inc. (US), Drägerwerk AG & Co. KGaA (Germany), Boston Scientific Corporation (US), Masimo Corporation (US), Omron Corporation (Japan), ARCHIMED SAS (Natus Medical) (France), Compumedics Limited (Australia), and Nonin Medical, Inc. (US). Companies continue investing in wearable technologies, connected monitoring platforms, AI-enabled analytics, and cloud-integrated healthcare solutions to strengthen their competitive positions.

About MarketsandMarkets™:

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Report Code: MD 2436 | Published: 12 June 2026 | Report Pages: 300 | Market Data Tables: 425 | Figures: 62

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.